Amphastar Pharmaceuticals AMPH Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's free cash flow margin?
- Amphastar Pharmaceuticals (AMPH) reported free cash flow margin of 18.8% in Q1 2026.
- How has Amphastar Pharmaceuticals's free cash flow margin changed year-over-year?
- Amphastar Pharmaceuticals's free cash flow margin decreased by 8.7% year-over-year, from 20.6% to 18.8%.
- What is the long-term trend for Amphastar Pharmaceuticals's free cash flow margin?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's free cash flow margin has grown at a 20.3% compound annual growth rate (CAGR), from 6.7% to 16.8%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.